Enforcement Report - Week of March 13, 2024
U.S. sanctions on Iran threaten access by some Iranians to medicines that treat diseases such as cancer and epilepsy, despite exemptions in the measures for imports of humanitarian goods, a report said on Tuesday.
The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling out a similar initiative, only with some extra incentives.
The Italian authorities have fined South African drugmaker Aspen €5.2m for abusing a dominant position in the market for cancer drugs, leading to calls for an EU-wide probe into a possible link between drug shortages and inflated pricing.
Inherited Gene Variation Helps Explain Drug Toxicity in Patients of East Asian Ancestry
NICE Backs Three Ulcerative Colitis Treatments